Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Da-Wei Ye"'
Autor:
Junjie Hu, Hongliang Dong, Yiming Dong, Runxuan Zhou, Wilhem Teixeira, Xingxing He, Da-Wei Ye, Gang Ti
Publikováno v:
iScience, Vol 27, Iss 4, Pp 109430- (2024)
Summary: An up-to-date comprehensive assessment of the cancer burden attributable to risk factors is essential for cancer prevention. We analyzed the population attributable fraction (PAF) of cancer disability-adjusted life years (DALYs) attributable
Externí odkaz:
https://doaj.org/article/dc4c228810e34207bc2109efab901cda
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
BackgroundThe incidence of kidney, bladder, and prostate cancer ranked ninth, sixth, and third in male cancers respectively, meanwhile, the incidence of testicular cancer also increased gradually in the past 30 years.ObjectiveTo study and present est
Externí odkaz:
https://doaj.org/article/6bc93e29ad274f27badfaa709c2cf274
Autor:
Xing-Xing He, Da-Wei Ye
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/ea23f4d5b4d94692a0d563d4a1e52229
Autor:
Meng-Meng Ge, Dan-Yang Li, Lu Wang, Long-Qing Zhang, Dai-Qiang Liu, Yu-Ke Tian, Da-Wei Ye, Zhi-Heng Liu, Ya-Qun Zhou, Hui Yang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 149, Iss , Pp 112912- (2022)
Cancer-induced bone pain (CIBP) treatment remains a clinical challenge because the pathophysiological mechanisms are not fully understood. Recently, it was verified that shifting microglial polarization toward the M2 phenotype reveals a potential str
Externí odkaz:
https://doaj.org/article/bb7bc5cbb11b48cf8fc0eed573f04283
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Hepatocellular carcinoma (HCC) is a common malignant tumor with high mortality and poor prognosis in the world. The low rate of early diagnosis, as well as the high risk of postoperative metastasis and recurrence, led to the poor clinical prognosis o
Externí odkaz:
https://doaj.org/article/547403cb2b3b45bda6fa090e76fa6ce3
Autor:
Nan Chen, Meng-Meng Ge, Dan-Yang Li, Xiao-Mei Wang, Dai-Qiang Liu, Da-Wei Ye, Yu-Ke Tian, Ya-Qun Zhou, Jian-Ping Chen
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 144, Iss , Pp 112331- (2021)
Chemotherapy-induced neuropathic pain is a debilitating and common side effect of cancer treatment and so far no effective drug is available for treatment of the serious side effect. Previous studies have demonstrated β2-adrenoreceptor (ADRB2) agoni
Externí odkaz:
https://doaj.org/article/e077944fe2614b26aa15925d8a136ef8
Autor:
Ya-Qun Zhou, Dai-Qiang Liu, Shu-Ping Chen, Nan Chen, Jia Sun, Xiao-Mei Wang, Dan-Yang Li, Yu-Ke Tian, Da-Wei Ye
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 129, Iss , Pp 110356- (2020)
Paclitaxel-induced neuropathic pain (PINP) is a dose-limiting side effect and is refractory to widely used analgesic drugs. Previous studies have demonstrated a protective role of peroxisome proliferator-activated receptor gama (PPARγ) in neuropathi
Externí odkaz:
https://doaj.org/article/900738ae3fae415da68ad0eb5138f837
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 125, Iss , Pp 110017- (2020)
Despite the growing knowledge of the mechanisms of chronic pain, the treatment of this disorder in the clinic remains a major challenge. Src-family protein tyrosine kinases (SFKs), a group of non-receptor protein tyrosine kinases, have been implicate
Externí odkaz:
https://doaj.org/article/22dbbfcb44fb4b4d8af385009215dafa
Autor:
Jia Sun, Ya-Qun Zhou, Shu-Ping Chen, Xiao-mei Wang, Bing-Yang Xu, Dan-Yang Li, Yu-Ke Tian, Da-Wei Ye
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 120, Iss , Pp - (2019)
Treating Cancer-induced bone pain (CIBP) continues to be a major clinical challenge and underlying mechanisms of CIBP remain unclear. Recently, emerging body of evidence suggested the endocannabinoid system (ECS) may play essential roles in CIBP. Her
Externí odkaz:
https://doaj.org/article/27a3f8b3e192465f9fbebe99895d4e80
Autor:
Ya-Qun Zhou, Dai-Qiang Liu, Shu-Ping Chen, Jia Sun, Xue-Rong Zhou, Heike Rittner, Wei Mei, Yu-Ke Tian, Hui-Xian Zhang, Fei Chen, Da-Wei Ye
Publikováno v:
Redox Biology, Vol 14, Iss , Pp 391-397 (2018)
Cancer-induced bone pain (CIBP) is a frequent complication in patients suffering from bone metastases. Previous studies have demonstrated a pivotal role of reactive oxygen species (ROS) in inflammatory and neuropathic pain, and ROS scavengers exhibit
Externí odkaz:
https://doaj.org/article/298388eb0edd49a7bdbd8d1900d2d125